Anal fissure. K60.2 Anal fissure, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Recipients of anti-fissure cream manufactured by Barij Essans Pharmaceutical Company along with Pidrolax syrup. Intervention 2: Control group: The recipients are 5%
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 10 Years
Inclusion criteria
Inclusion criteria: Fischer's disease Age range 2 to 10 years
Exclusion criteria
Exclusion criteria: 1. Hemorrhoids 2. Anal fistula 3. Anal abscess 4. Malignant diseases 5. Food allergies 6. IBD diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of bleeding. Timepoint: Days 0, 15, and 30 from the start of treatment. Method of measurement: Likert 4 options from 0 to 3.;Severity of pain. Timepoint: Days 0, 15 and 30 from the start of treatment. Method of measurement: Numerical score (NRS-11).;Grade of disease. Timepoint: Days 0, 15 and 30 from the start of treatment. Method of measurement: Grade 0: Healed, Grade 1: Fissure with internal anal sphincter evident. Grade 2: Deeper fissures with internal anal sphincter evident in a wider manner, Grade 3: Fissure of unknown depth, Grade 4: With perianal fistula. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of drug used. Timepoint: On days 15 and 30 from the start of treatment. Method of measurement: Questioning the patient, clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Akbari
Kashan University of Medical Sciences
Outcome results
None listed